p53 gene mutations in primary lung tumors are conserved in brain metastases |
| |
Authors: | Uwe Schlegel Myrna R. Rosenfeld Matthias Volkenandt Marc Rosenblum Josep Dalmau Henry Furneaux |
| |
Affiliation: | (1) From the Laboratory of Molecular Neuro-Oncology, Memorial Sloan-Kettering Cancer Center, USA;(2) Laboratory of Molecular Pharmacology, Memorial Sloan-Kettering Cancer Center, USA;(3) Department of Pathology, Memorial Sloan-Kettering Cancer Center, USA;(4) Laboratory of Molecular Neuro-Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, 10021 New York, NY, USA |
| |
Abstract: | The p53 product is frequently mutated in human tumors. Both acquired and inherited mutations have been described. These mutations transform p53 from a growth suppressor gene to a transforming oncogene. We examined tissue from 6 patients with primary lung carcinoma and the corresponding brain metastases for the presence of p53 mutations by immunohistochemistry. We then confirmed and characterized the mutations by single strand conformation analysis and by direct sequence analysis. All 6 patients had primary and metastatic tumor expressing a mutant p53. The mutations were all G-T transversions and mapped to exons 5, 6, 7, and 8. The mutations in the primary tumors were precisely conserved in the brain metastases. |
| |
Keywords: | p53 lung tumors brain metastasis |
本文献已被 SpringerLink 等数据库收录! |
|